Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability

Expert Opinion on Drug Safety · Published 2026-06-30 · DOI 10.1080/14740338.2026.2687628

Authors (9)

Tiffany R. Price, Chia-Yuan Chang, Kirya Skinner, Michael Dinneny, Parmida Nafezi, Lisa Kuramoto, Mary A. De Vera, Neil R. Cashman, Jacquelyn J. Cragg

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Price, T., Chang, C., Skinner, K., et al. (2026). Could anticholinergics accelerate ALS progression? A critical perspective on drug safety and disease vulnerability. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2026.2687628

Related articles